𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Commentary: Appropriate cancer chemotherapy for ataxia-telangiectasia patients

✍ Scribed by Sandoval, Claudio; Swift, Michael

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
24 KB
Volume
34
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer risk in heterozygotes for ataxia-
Cancer risk in heterozygotes for ataxia-telangiectasia
✍ Béatrice Geoffroy-Perez; Nicolas Janin; Katia Ossian; Anthony Laugé; Marie-Franç 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 60 KB

Epidemiological studies have suggested that ataxia-telangiectasia (AT) heterozygotes have a predisposition to cancer, especially breast cancer in women. Now, haplotyping can identify heterozygotes for AT mutation (ATM) in AT families, allowing the risk of cancer associated with ATM heterozygosity st

Variation in breast cancer risk of heter
Variation in breast cancer risk of heterozygotes for ataxia-telangiectasia according to environmental factors
✍ Béatrice Geoffroy-Perez; Nicolas Janin; Katia Ossian; Anthony Laugé; Dominique S 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 68 KB

## Abstract Ataxia‐telangiectasia (AT) is a rare autosomal recessive disorder, characterized by progressive neuronal degeneration, immunological deficiency, radio‐sensitivity and an increased risk of cancer. Although several studies have confirmed that AT heterozygosis increases the risk of breast

Is the increase in orchiectomy for prost
Is the increase in orchiectomy for prostate cancer patients appropriate?
✍ Gerald W. Chodak 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

An increase in the use of bilateral orchiectomy has been observed coinciding with a decrease in the use of lutenizing hormone‐releasing hormone therapy for men who require castration for their prostate cancer. This finding has raised 2 questions: 1) is this good or bad for patients? and 2) are econo

Partial splenic embolization for cancer
Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy
✍ Christopher R. Kauffman; Armeen Mahvash; Scott Kopetz; Robert A. Wolff; Joe Enso 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract ## BACKGROUND. Partial splenic embolization (PSE) has been used to improve hematologic parameters related to hypersplenism. The purpose of this study was to review our institutional experience with PSE for cancer patients with thrombocytopenia because of splenic sequestration precludin